Home  »  Finance   »  Gear up for the change! Reata Pharmaceuticals Inc....

Gear up for the change! Reata Pharmaceuticals Inc. (RETA) has hit the volume of 354651

Let’s start up with the current stock price of Reata Pharmaceuticals Inc. (RETA), which is $36.71 to be very precise. The Stock rose vividly during the last session to $36.855 after opening rate of $35.72 while the lowest price it went was recorded $35.245 before closing at $35.65.Recently in News on November 10, 2022, Reata Pharmaceuticals Announces Participation in the Guggenheim 2022 Immunology and Neurology Conference and the Stifel 2022 Healthcare Conference. Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” or “we”), a clinical-stage biopharmaceutical company, today announced that management will participate in the Guggenheim 2022 Immunology & Neurology Conference on November 14 – 15, 2022 in New York, NY, and will participate in the Stifel 2022 Healthcare Conference on November 15 – 16, 2022 in New York, NY. You can read further details here

Reata Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $43.90 on 11/15/22, with the lowest value was $18.47 for the same time period, recorded on 08/17/22.

Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report

Sponsored

Reata Pharmaceuticals Inc. (RETA) full year performance was -58.75%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Reata Pharmaceuticals Inc. shares are logging -61.50% during the 52-week period from high price, and 98.75% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $18.47 and $95.34.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 354651 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Reata Pharmaceuticals Inc. (RETA) recorded performance in the market was 39.21%, having the revenues showcasing 43.74% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.26B, as it employees total of 346 workers.

Specialists analysis on Reata Pharmaceuticals Inc. (RETA)

During the last month, 0 analysts gave the Reata Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 29.52, with a change in the price was noted +0.22. In a similar fashion, Reata Pharmaceuticals Inc. posted a movement of +0.60% for the period of last 100 days, recording 822,976 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for RETA is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Trends and Technical analysis: Reata Pharmaceuticals Inc. (RETA)

Raw Stochastic average of Reata Pharmaceuticals Inc. in the period of last 50 days is set at 67.42%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 51.25%. In the last 20 days, the company’s Stochastic %K was 48.11% and its Stochastic %D was recorded 49.78%.

Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 39.21%. Additionally, trading for the stock in the period of the last six months notably improved by 36.57%, alongside a downfall of -58.75% for the period of the last 12 months. The shares increased approximately by -3.60% in the 7-day charts and went down by 11.78% in the period of the last 30 days. Common stock shares were driven by 43.74% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]